BeyondSpring (BYSI) IV bid into data
Get Alerts BYSI Hot Sheet
Join SI Premium – FREE
BeyondSpring (NASDAQ: BYSI) 30-day option implied volatility is at 271; compared to its 52-week range of 73 to 293 into the FDA has a Prescription Drug User Fee Act target action date set for the plinabulin NDA of November 30. Call put ratio 1 call to 1 put.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Netflix (NFLX) call put ratio 2.2 calls to 1 put into quarter results
- Citigroup (C) call put ratio 1.2 calls to 1 put into quarter results
- Vaxcyte, Inc (PCVX) call put ratio 1.6 calls to 1 put as share price down 2.4%
Create E-mail Alert Related Categories
OptionsRelated Entities
Options, PDUFA, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share